Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | ANPEP | P15144 | 1/20 | 0.54 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | CASR | P41180 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23367774 | 0.84 | ANPEP (0.58) | ANPEPERAP2CHRM2HTTSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL30945857 | 0.82 | ANPEP (0.56) | ANPEPERAP2CHRM2HTTSMN1; SMN2 | |
| SCHEMBL17238292 | 0.82 | ANPEP (0.56) | ANPEPERAP2CHRM2HTTSMN1; SMN2 | |
| SCHEMBL19865693 | 0.82 | L3MBTL1 (0.57) | MEN1KMT2AL3MBTL1CHRM2HTT | |
| SCHEMBL10263818 | 0.81 | L3MBTL1 (0.56) | MEN1KMT2AL3MBTL1HTTSMN1; SMN2 | |
| SCHEMBL21245400 | 0.81 | ANPEP (0.63) | ANPEPERAP2CHRM2HTTALDH1A1 | |
| SCHEMBL20502219 | 0.81 | L3MBTL1 (0.56) | MEN1KMT2AL3MBTL1HTTSMN1; SMN2 | |
| SCHEMBL17504540 | 0.81 | ANPEP (0.63) | ANPEPERAP2CHRM2HTTALDH1A1 | |
| SCHEMBL13995687 | 0.81 | ALDH1A1 (0.58) | MEN1KMT2AL3MBTL1ANPEPHTT | |
| SCHEMBL696773 | 0.81 | MEN1 (0.58) | MEN1KMT2AL3MBTL1CHRM2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230025575-A1 | PROCESS FOR PREPARING AMINES OVER A COPPER CATALYST | BASF SE (DE) | 2023-01-26 | — | — | US | disclosed |
| EP-4069418-A1 | PROCESS FOR PREPARING AMINES OVER A COPPER CATALYST | BASF SE (DE) | 2022-10-12 | — | — | EP | disclosed |
| CN-114746179-A | Method for producing amines on copper catalysts | 巴斯夫欧洲公司 | 2022-07-12 | — | — | CN | disclosed |
| US-11225588-B2 | Method for producing a curing agent for low-emission epoxy resin compositions | SIKA TECHNOLOGY AG (CH) | 2022-01-18 | — | — | US | disclosed |
| EP-3596150-B1 | METHOD FOR THE PREPARATION OF A CROSS-LINKER FOR LOW EMISSION EPOXY RESIN COMPOSITIONS | SIKA TECH AG (CH) | 2021-04-07 | — | — | EP | disclosed |
| US-20200040215-A1 | METHOD FOR PRODUCING A CURING AGENT FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2020-02-06 | — | — | US | disclosed |
| WO-2018166996-A1 | METHOD FOR PRODUCING A CURING AGENT FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2018-09-20 | — | — | WO | disclosed |
| EP-3375802-A1 | METHOD FOR THE PREPARATION OF A CROSS-LINKER FOR LOW EMISSION EPOXY RESIN COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2018-09-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230025575-A1 | PROCESS FOR PREPARING AMINES OVER A COPPER CATALYST | AOC2, SOD1, AOC3 | MEN1 1189/4885KMT2A 224/4885L3MBTL1 3423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.